Skip to Content

93 7456 (Glipizide and Metformin Hydrochloride 2.5 mg / 500 mg)

Pill with imprint 93 7456 is White, Elliptical / Oval and has been identified as Glipizide and Metformin Hydrochloride 2.5 mg / 500 mg. It is supplied by Teva Pharmaceuticals USA.

Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glipizide/metformin 2.5 mg / 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7456

Glipizide and metformin hydrochloride 2.5 mg / 500 mg 93 7456
Glipizide and metformin hydrochloride 2.5 mg / 500 mg 93 7456
Glipizide and metformin hydrochloride 2.5 mg / 500 mg 93 7456
Glipizide and metformin hydrochloride 2.5 mg / 500 mg 93 7456 Front
Glipizide and metformin hydrochloride 2.5 mg / 500 mg 93 7456 Back
Glipizide and metformin hydrochloride 2.5 mg / 500 mg 93 7456

Glipizide and Metformin Hydrochloride

Imprint
93 7456
Strength
2.5 mg / 500 mg
Color
White
Size
17.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
corn starch, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, polyethylene glycol 3350, polyvinyl alcohol, povidone k30, povidone k90, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00093-7456 Teva Pharmaceuticals USA, Inc.
42291-0305 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.